Alto Pharmacy is a digital pharmacy focused on delivering prescriptions to patients without delivery fees. As with physical pharmacies, patients are able to chat directly with Alto pharmacists to ask questions about their care across general health, sexual health, heart health, fertility, and more. Alto Pharmacy was founded in 2015 by Jamie Karraker, Mattieu Gamache-Asselin, and Vladimir Blumen and is headquartered in San Francisco, CA.
Alto Pharmacy is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Alto Pharmacy pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Alto Pharmacy is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
---|---|---|---|---|
9/25/2023 | Series CC-4, EE-1 and F | $120MM raised | $XXX.XX | $XXX.XX |
1/27/2022 | Series EE | $185.52MM raised | $XXX.XX | $XXX.XX |
2/4/2020 | Series DD | $246.4MM raised | $XXX.XX | $XXX.XX |
6/19/2019 | Series CC | $30MM raised | $XXX.XX | $XXX.XX |
12/5/2018 | Series CC-1, CC-2 and CC-3 | $50.44MM raised | $XXX.XX | $XXX.XX |
6/12/2017 | Series BB | $17.15MM raised | $XXX.XX | $XXX.XX |
6/10/2016 | Series AA and AA-1 | $6.6MM raised | $XXX.XX | $XXX.XX |